Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 6.53 --0 (-0%)
Previous Close $6.53    52 Week High
Open $6.53    52 Week Low
Day High $6.53    P/E N/A 
Day Low $6.53    EPS
Volume 642